{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-020878","form_type":"8-K","ticker":"ECOR","cik":"0001560258","company_name":"electroCore, Inc.","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.737687+00:00","generated_at":"2026-05-17T00:16:55.336445+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"electroCore Q3 net sales $8.7M up 33% YoY; raises FY2025 revenue guidance to $31.5-$32.5M","bullets":["Net sales $8.7M, 33% increase YoY; YTD net sales $22.8M, up 26% vs first nine months of 2024.","Net loss $3.4M ($0.40 per share) vs $2.5M loss in Q3 2024; adjusted EBITDA net loss $2.0M vs $2.1M.","FY2025 revenue guidance raised to $31.5-$32.5M; expects first quarter of positive adjusted EBITDA in H2 2026.","Total cash $13.2M at Sep 30, 2025, up from $12.2M at Dec 31, 2024.","Prescription devices sales $6.81M (+19% YoY); health & wellness $1.88M (+121% YoY)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-020878","json":"https://secwatch.observer/filing/0001493152-25-020878.json","markdown":"https://secwatch.observer/filing/0001493152-25-020878.md","text":"https://secwatch.observer/filing/0001493152-25-020878.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560258/000149315225020878/0001493152-25-020878-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560258/000149315225020878/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:16:55.336445+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}